Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the ...
LONDON, March 13, 2025 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and ...
Virax Biolabs' technology supports vaccine efficacy assessments and long-term immune protection monitoring. The company collaborates with vaccine developers to enhance transparency and advance ...
An institutional investor recently bought a new position in Virax Biolabs Group stock. XTX Topco Ltd purchased a new position in shares of Virax Biolabs Group Limited (NASDAQ:VRAX – Free Report ...
On Thursday, Virax Biolabs Group Limited (NASDAQ:VRAX) said it supports the U.S. Department of Health and Human Services’ focus on vaccine efficacy transparency, emphasizing the need for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback